Igenica Biotherapeutics' Series C Round

Igenica Biotherapeutics raised a round of funding on June 12, 2012.

Igenica is focused on the discovery and development of antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. Igenica is the only biotherapeutic company that fully powers the ADC …

Articles about Igenica Biotherapeutics' Series C Round: